Cytokinetics Inc (CYTK)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -536,248 | -524,626 | -506,090 | -497,967 | -496,205 | -495,817 | -481,993 | -370,818 | -324,202 | -218,876 | -179,636 | -223,559 | -186,313 | -201,016 | -126,631 | -104,192 | -93,943 | -81,242 | -110,353 | -104,711 |
| Revenue (ttm) | US$ in thousands | 18,474 | 3,219 | 3,134 | 3,752 | 7,530 | 7,815 | 9,952 | 98,053 | 94,588 | 148,231 | 151,153 | 65,028 | 70,428 | 21,550 | 57,801 | 58,551 | 55,828 | 54,318 | 18,685 | 22,229 |
| Operating profit margin | -2,902.72% | -16,297.79% | -16,148.37% | -13,272.04% | -6,589.71% | -6,344.43% | -4,843.18% | -378.18% | -342.75% | -147.66% | -118.84% | -343.79% | -264.54% | -932.79% | -219.08% | -177.95% | -168.27% | -149.57% | -590.60% | -471.06% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-536,248K ÷ $18,474K
= -2,902.72%
The operating profit margin of Cytokinetics Inc has been experiencing significant fluctuations over the quarters based on the provided data. The margin started at negative values, indicating that the company was incurring operating losses exceeding its revenues.
The trend shows that the operating profit margin deteriorated further in the subsequent periods, reaching extreme negative percentages, such as -4,843.18%, -6,344.43%, and even -13,272.04%. These values reflect that the company's operating expenses were substantially higher than the revenue generated from its core business activities during those periods.
However, there seems to be a substantial improvement in the operating profit margin by the end of December 31, 2024, where the margin improved to -2,902.72%. This improvement indicates that the company may have taken measures to enhance operational efficiency or increase revenue streams, leading to a reduction in operating losses relative to revenue.
Overall, the operating profit margin trajectory of Cytokinetics Inc demonstrates the challenges faced by the company in managing its operating expenses in relation to its revenues. Further analysis of the company's financial and operational strategies would be necessary to understand the driving factors behind these fluctuations.
Peer comparison
Dec 31, 2024